Development of ezetimibe eutectic with improved biopharmaceutical and mechanical properties to design an optimized oral solid dosage formulation-Reference-Cited by-同舟云学术

Development of ezetimibe eutectic with improved biopharmaceutical and mechanical properties to design an optimized oral solid dosage formulation

Published:2022-11-08 Issue:10 Volume:27 Page:989-998
ISSN:1083-7450
Container-title:Pharmaceutical Development and Technology
language:en
Short-container-title:Pharmaceutical Development and Technology

Author:

Roy Parag¹^ORCID,Kumari Nimmy¹²^ORCID,Pandey Noopur¹^ORCID,Gour Abhishek³,Raj Amit¹^ORCID,Srividya B.¹,Nandi Utpal³^ORCID,Ghosh Animesh¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences and Technology, Solid State Pharmaceutics Research Laboratory, Birla Institute of Technology, Mesra, Ranchi, India

2. Department of Pharmacy, Muzaffarpur Institute of Technology, Muzaffarpur, Muzaffarpur, India

3. PK-PD, Toxicology Division, CSIR-Indian Institute of Integrative Medicine, Jammu, India

Funder

AICTE, Govt. of India, New Delhi under Research Promotion Scheme

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10837450.2022.2143525

Reference45 articles.

1. Ezetimibe: cholesterol lowering and beyond

2. Eutectic mixtures as an approach to enhance solubility, dissolution rate and oral bioavailability of poorly water-soluble drugs

3. Is Failure of Cocrystallization Actually a Failure? Eutectic Formation in Cocrystal Screening of Hesperetin

4. Eutectics as improved pharmaceutical materials: design, properties and characterization

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eutectic mixtures containing the active pharmaceutical ingredient ezetimibe: Phase diagrams, solid state characterization and dissolution profiles;Journal of Crystal Growth;2024-09

2. Eutectic Mixture of Fenofibric Acid and Syringic Acid: Improvement of Dissolution Rate and Its Antihyperlipidemic Activity;ChemistrySelect;2023-05-25

3. Eutectic Mixtures Containing the Active Pharmaceutical Ingredient Ezetimibe: Phase Diagrams, Solid State Characterization and Dissolution Profiles;2023